Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Centessa Pharmaceuticals (uk) Limited

Clinical trials sponsored by Centessa Pharmaceuticals (uk) Limited, explained in plain language.

Now part of Centessa Pharmaceuticals plc CNTA NASDAQ

Develops novel therapies across multiple disease areas.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 5 Terminated 1

Cancer drug study halted early: what we know

Disease control Terminated

This study tested a new drug called LB101 in 25 adults with advanced solid tumors that had stopped responding to standard treatments. The goal was to check safety and see if the drug shrank tumors. The study was terminated early, so results are limited.

Phase: PHASE1, PHASE2 • Sponsor: Centessa Pharmaceuticals (UK) Limited • Aim: Disease control

Last updated Jun 27, 2026 07:51 UTC